Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue

Clinical trial NCT07311070 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07311070
Sponsor: Daryoush Hamidi Alamdari, PhD
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Basal Cell Carcinoma (BCC)Inoperable Disease Morpheaform Basal Cell Carcinoma Noduloulcerative Basal Cell Carcinoma Infiltrative Basal Cell Carcinoma

Start date: 2025-10-21
Primary completion: 2026-01-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.